Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Class A and Class B Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income/(Loss)	Accumulated Deficit	Non- Controlling Interest
Balances beginning ( in shares) at Dec. 31, 2022		604,674
Balance beginning at Dec. 31, 2022	$ 305,035	$ 59	$ 2,213,603	$ 671	$ (1,908,307)	$ (991)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		4,571
Issuance of common stock upon exercise of stock options	11,140	$ 1	11,139
Issuance of common stock under Employee Stock Purchase Plan (in shares)		639
Issuance of common stock under Employee Stock Purchase Plan	19,921		19,921
Vesting of restricted stock units (in shares)		6,417
Stock-based compensation expense	397,266		397,266
Other comprehensive income/(loss)	(14,373)			(14,766)		393
Net loss	(554,789)				(551,090)	(3,699)
Balance ending (Shares) at Jun. 30, 2023		616,301
Balance ending at Jun. 30, 2023	164,200	$ 60	2,641,929	(14,095)	(2,459,397)	(4,297)
Balances beginning ( in shares) at Mar. 31, 2023		610,487
Balance beginning at Mar. 31, 2023	245,182	$ 60	2,424,340	62	(2,176,620)	(2,660)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		2,308
Issuance of common stock upon exercise of stock options	5,227		5,227
Vesting of restricted stock units (in shares)		3,506
Stock-based compensation expense	212,362		212,362
Other comprehensive income/(loss)	(13,730)			(14,157)		427
Net loss	(284,841)				(282,777)	(2,064)
Balance ending (Shares) at Jun. 30, 2023		616,301
Balance ending at Jun. 30, 2023	$ 164,200	$ 60	2,641,929	(14,095)	(2,459,397)	(4,297)
Balances beginning ( in shares) at Dec. 31, 2023	631,221	631,221
Balance beginning at Dec. 31, 2023	$ 68,626	$ 61	3,134,946	1,536	(3,060,253)	(7,664)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	4,286	4,286
Issuance of common stock upon exercise of stock options	$ 12,333		12,333
Issuance of common stock under Employee Stock Purchase Plan (in shares)		1,085
Issuance of common stock under Employee Stock Purchase Plan	24,742		24,742
Vesting of restricted stock units (in shares)		10,019
Stock-based compensation expense	492,393		492,393
Other comprehensive income/(loss)	(7,678)			(7,765)		87
Net loss	$ (479,115)				(476,487)	(2,628)
Balance ending (Shares) at Jun. 30, 2024	646,611	646,611
Balance ending at Jun. 30, 2024	$ 111,301	$ 61	3,664,414	(6,229)	(3,536,740)	(10,205)
Balances beginning ( in shares) at Mar. 31, 2024		639,734
Balance beginning at Mar. 31, 2024	62,687	$ 61	3,407,986	(5,589)	(3,330,857)	(8,914)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,692
Issuance of common stock upon exercise of stock options	4,537		4,537
Vesting of restricted stock units (in shares)		5,185
Stock-based compensation expense	251,891		251,891
Other comprehensive income/(loss)	(619)			(640)		21
Net loss	$ (207,195)				(205,883)	(1,312)
Balance ending (Shares) at Jun. 30, 2024	646,611	646,611
Balance ending at Jun. 30, 2024	$ 111,301	$ 61	$ 3,664,414	$ (6,229)	$ (3,536,740)	$ (10,205)